[{"NetIncomeLoss_1_Q2_USD":-34416000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":20161000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10384000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":29482511.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":28639210.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":6345000.0,"LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_0_Q2_USD":108000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":42.91,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":377238000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":69701000.0,"PaymentsToAcquireInvestments_2_Q2_USD":190450000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":731525.0,"DividendsCommonStockCash_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":17.66,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1597000.0,"AociBeforeTaxAttributableToParent_0_Q2_USD":-5000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2388000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2520000.0,"CommonStockSharesIssued_0_Q2_shares":29543810.0,"Assets_0_Q2_USD":577188000.0,"ShareBasedCompensation_2_Q2_USD":13288000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":7327000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":50.45,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1014000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1622000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1328000.0,"AssetsCurrent_0_Q2_USD":567098000.0,"OperatingLeaseImpairmentLoss_2_Q2_USD":677000.0,"DeferredRentCreditCurrent_0_Q2_USD":35000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1128000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":729000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":44333000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":24147000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":42.91,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":9414000.0,"LessorOperatingLeasePaymentsToBeReceived_0_Q2_USD":272000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":251947000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":499000.0,"CommonStockValue_0_Q2_USD":3000.0,"InvestmentIncomeNet_2_Q2_USD":249000.0,"InvestmentIncomeNet_1_Q2_USD":106000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":164000.0,"PrepaidExpenseAndOtherAssetsNoncurrent_0_Q2_USD":300000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":273076000.0,"IncreaseDecreaseInDeferredCharges_2_Q2_USD":-35000.0,"OtherAssetsCurrent_0_Q2_USD":783000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-64957000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-34430000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1101000.0,"OtherAssetsNoncurrent_0_Q2_USD":729000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":345649000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":6437000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":769319000.0,"Liabilities_0_Q2_USD":16850000.0,"DefinedContributionPlanCostRecognized_2_Q2_USD":300000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":104000.0,"OperatingLeaseLiability_0_Q2_USD":8400000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":233000.0,"LitigationReserve_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"OperatingIncomeLoss_1_Q2_USD":-34531000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":5149172.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-64913000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-34416000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7466000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-50072000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2547000.0,"LiabilitiesCurrent_0_Q2_USD":10309000.0,"AccountsPayableCurrent_0_Q2_USD":1966000.0,"NonoperatingIncomeExpense_2_Q2_USD":-419000.0,"NonoperatingIncomeExpense_1_Q2_USD":115000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":23065000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3059000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":948000.0,"RestrictedCashNoncurrent_0_Q2_USD":261000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0591,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":377238000.0,"SubleaseIncome_2_Q2_USD":9000.0,"SubleaseIncome_1_Q2_USD":9000.0,"SecurityDeposit_0_Q2_USD":400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":345910000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_2_Q2_USD":-44000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_1_Q2_USD":-14000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":159518.0,"OperatingLeasePayments_2_Q2_USD":490000.0,"PrepaidInsurance_0_Q2_USD":46000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":310539000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1773000.0,"NetIncomeLoss_2_Q2_USD":-64913000.0,"LessorOperatingLeasePaymentsToBeReceivedTwoYears_0_Q2_USD":110000.0,"OperatingIncomeLoss_2_Q2_USD":-64494000.0,"CommonStockSharesOutstanding_0_Q2_shares":29543810.0,"MarketableSecurities_0_Q2_USD":197979000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":128.16,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":19.18,"OperatingLeaseCost_2_Q2_USD":748000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":577188000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2068000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":13288000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":7466000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":84000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":35625.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q2_USD":-14000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1963000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":292705000.0,"OperatingExpenses_2_Q2_USD":64494000.0,"LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_0_Q2_USD":54000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.27,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.17,"ProfitLoss_2_Q2_USD":-64913000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":104000.0,"DeferredOfferingCosts_0_Q2_USD":405000.0,"StockholdersEquity_0_Q2_USD":560338000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":786000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-423000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5149172.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":3223617.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-208979000.0,"LeaseCost_2_Q2_USD":739000.0,"OperatingExpenses_1_Q2_USD":34531000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":588000.0,"Ticker":"KRTX","CIK":"1771917","name":"KARUNA THERAPEUTICS, INC.","OfficialName":"Karuna Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3925750608.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]